EMD 1.96% 5.2¢ emyria limited

Ann: Emyria Pursuing Registration of EMD-003 in CY2021, page-16

  1. 9,585 Posts.
    lightbulb Created with Sketch. 2892
    Is it just me, or is this data not independent - so for the purposes of approvals - useless.
    I mean it potentially provides indications of what may work, or may not. But that's about it - still got to get verifiable independent data for things such as FDA approval.

    And the ethics of owning the medication AND providing the patients AND the doctors (mostly just GPs) to study results....how did this even get this far?





 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.